NEW YORK (GenomeWeb News) – DeltaDot will partner with the Qatar Science and Technology Park to open a proteomics research and testing services lab in Doha, the London-based company said on Monday.

Under the plan, QSTP will contribute $15 million to the partnership, while DeltaDot will provide staff, expertise, and it will grant QSTP an exclusive regional license to its technology.

Projects already in the works include biomarker studies for breast cancer and colorectal cancer and the metallic content of proteins, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.